Table 3.
Cancer
|
Nonmalignant control
|
|||||||
---|---|---|---|---|---|---|---|---|
+++ (%) | ++ (%) | + (%) | −ve (%) | +++ (%) | ++ (%) | + (%) | −ve | |
Bladder Ca | — | 38 | 46 | 16 | 68 | 29 | 3 | — |
Liver Ca | 15 | 28 | 32 | 25 | 56 | 36 | 8 | — |
Colon Ca | 8 | 38 | 51 | 3 | 71 | 23 | 6 | — |
Ca, cancer.
The intensity of immunostaining was scored as follows: (−ve), no detectable immunostaining or basal immunostaining in <10% cells; (+), mild immunostaining in 10–30% cells; (++), moderate immunostaining in 30–50% cells and (+++), intense immunostaining in >50% of the cells showing cytoplasmic staining.
Shaded portion represents staining pattern in non-cancer specimens.